The University of Southampton
University of Southampton Institutional Repository

Monomeric IgG in intravenous Ig preparations is a functional antagonist of Fc gamma RII and Fc gamma RIIIb

Monomeric IgG in intravenous Ig preparations is a functional antagonist of Fc gamma RII and Fc gamma RIIIb
Monomeric IgG in intravenous Ig preparations is a functional antagonist of Fc gamma RII and Fc gamma RIIIb
Intravenous Ig preparations (IVIg), originally developed as a substitution therapy for patients with low plasma IgG, are nowadays frequently used in the treatment of various immune diseases. However, the mechanism of action of IVIg in these diseases remains elusive and is often referred to as "immunomodulatory." We hypothesized that monomeric IgG may act as a low-affinity FcR antagonist and sought experimental evidence for this hypothesis. Human neutrophils as well FcRIIa-transfected IIA1.6 cells were used as FcR-positive cells and aggregated IgG (aIgG) or stable dimeric IgG as FcR-specific agonists for these cells. We found that monomeric IgG purified from IVIg at concentrations similar to that of IgG in plasma, diminished the binding of stable dimeric IgG to FcRIIa transfectants, reduced aIgG-induced influx of Ca2+ ions into the cytosol of neutrophils, and attenuated the aIgG-induced release of elastase. Notably, monomeric IgG by itself did not elicit these responses, nor did it affect these processes in response to fMLP. Absorption of IgG from normal plasma revealed that plasma IgG exerted similar effects as monomeric IgG in IVIg. In addition, adding monomeric IgG to blood of healthy volunteers showed a dose-dependent decrease of aIgG-induced elastase release. Finally, we observed decreased aIgG-induced polymorphonuclear neutrophil responses in two hypogammaglobulinemic patients upon treatment with IVIg. We conclude that monomeric IgG at physiological levels acts as a low-affinity FcR antagonist. Moreover, FcR antagonism constitutes an immunomodulatory effect of IVIg.
0022-1767
332-339
Mirre, E.
f844cdaf-7642-4fbf-b606-aa8cb985ea64
Teeling, J.L.
fcde1c8e-e5f8-4747-9f3a-6bdb5cd87d0a
Meer, J.W.M.
8b8b52f0-8bc0-4c67-a05d-7392d30a3df8
Meeker, W.K.
2bd64440-803b-44c4-bd96-5826fdabc2ae
Hack, C.E.
30fe6b07-f781-4eba-8476-5b4f509c36f8
Mirre, E.
f844cdaf-7642-4fbf-b606-aa8cb985ea64
Teeling, J.L.
fcde1c8e-e5f8-4747-9f3a-6bdb5cd87d0a
Meer, J.W.M.
8b8b52f0-8bc0-4c67-a05d-7392d30a3df8
Meeker, W.K.
2bd64440-803b-44c4-bd96-5826fdabc2ae
Hack, C.E.
30fe6b07-f781-4eba-8476-5b4f509c36f8

Mirre, E., Teeling, J.L., Meer, J.W.M., Meeker, W.K. and Hack, C.E. (2004) Monomeric IgG in intravenous Ig preparations is a functional antagonist of Fc gamma RII and Fc gamma RIIIb. Journal of Immunology, 173, 332-339.

Record type: Article

Abstract

Intravenous Ig preparations (IVIg), originally developed as a substitution therapy for patients with low plasma IgG, are nowadays frequently used in the treatment of various immune diseases. However, the mechanism of action of IVIg in these diseases remains elusive and is often referred to as "immunomodulatory." We hypothesized that monomeric IgG may act as a low-affinity FcR antagonist and sought experimental evidence for this hypothesis. Human neutrophils as well FcRIIa-transfected IIA1.6 cells were used as FcR-positive cells and aggregated IgG (aIgG) or stable dimeric IgG as FcR-specific agonists for these cells. We found that monomeric IgG purified from IVIg at concentrations similar to that of IgG in plasma, diminished the binding of stable dimeric IgG to FcRIIa transfectants, reduced aIgG-induced influx of Ca2+ ions into the cytosol of neutrophils, and attenuated the aIgG-induced release of elastase. Notably, monomeric IgG by itself did not elicit these responses, nor did it affect these processes in response to fMLP. Absorption of IgG from normal plasma revealed that plasma IgG exerted similar effects as monomeric IgG in IVIg. In addition, adding monomeric IgG to blood of healthy volunteers showed a dose-dependent decrease of aIgG-induced elastase release. Finally, we observed decreased aIgG-induced polymorphonuclear neutrophil responses in two hypogammaglobulinemic patients upon treatment with IVIg. We conclude that monomeric IgG at physiological levels acts as a low-affinity FcR antagonist. Moreover, FcR antagonism constitutes an immunomodulatory effect of IVIg.

This record has no associated files available for download.

More information

Published date: 1 July 2004

Identifiers

Local EPrints ID: 56740
URI: http://eprints.soton.ac.uk/id/eprint/56740
ISSN: 0022-1767
PURE UUID: d06c2301-3d79-454f-b507-bb1a453e126e
ORCID for J.L. Teeling: ORCID iD orcid.org/0000-0003-4004-7391

Catalogue record

Date deposited: 07 Aug 2008
Last modified: 23 Jul 2022 01:53

Export record

Contributors

Author: E. Mirre
Author: J.L. Teeling ORCID iD
Author: J.W.M. Meer
Author: W.K. Meeker
Author: C.E. Hack

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×